DeepMed Research

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Phase 4

Withdrawn

Conditions: Hepatitis C Virus Infection, Response to Therapy of

Interventions: Drug: Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]

First Posted Date: 2017-12-22

Last Posted Date: 2020-04-20

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03381859

Locations: 🇪🇬
Kasr Alainy Hospital, Cairo, Almanial, Egypt

Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Phase 2

Withdrawn

Conditions: Sars-CoV2
Respiratory Distress Syndrome, Adult

Interventions: Device: Hypothermia
Device: Standard of Care
Drug: Neuromuscular Blocking Agents

First Posted Date: 2017-12-19

Last Posted Date: 2021-04-30

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03376854

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Helping Veterans With SMI "StayQuit" From Smoking After Inpatient Hospitalization

Not Applicable

Completed

Conditions: StayQuit Intervention

Interventions: Behavioral: StayQuit

First Posted Date: 2017-12-08

Last Posted Date: 2020-04-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 29

Registration Number: NCT03367520

Locations: 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States

Biologic Mechanisms for Pain Variation After Physical Activity in Osteoarthritis

Not Applicable

Completed

Conditions: Physical Activity
Mitochondrial Pathology
Osteoarthritis, Knee
Pain

Interventions: Behavioral: Walking

First Posted Date: 2017-11-17

Last Posted Date: 2022-09-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 13

Registration Number: NCT03344913

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Hypothyroidism Treated With Calcitonin

Phase 4

Completed

Conditions: Hypothyroidism

Interventions: Drug: Calcitonin

First Posted Date: 2017-11-14

Last Posted Date: 2022-02-21

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 11

Registration Number: NCT03342001

Locations: 🇺🇸
University of Maryland Center for Diabetes and Endocrinology, Baltimore, Maryland, United States

Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya

Phase 3

Completed

Conditions: HIV
Smoking Cessation

Interventions: Drug: Bupropion
Behavioral: Positively smoke free
Other: Brief advice to quit smoking

First Posted Date: 2017-11-14

Last Posted Date: 2025-02-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 300

Registration Number: NCT03342027

Locations: 🇰🇪
Center for International Health, Education, and Biosecurity (CIHEB), Kilimani, Nairobi, Kenya

Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation

Phase 3

Terminated

Conditions: Heart Disease End Stage
Heart Failure，Congestive

Interventions: Drug: Frozen Plasma Product, Human
Drug: Kcentra

First Posted Date: 2017-11-14

Last Posted Date: 2025-05-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 14

Registration Number: NCT03341156

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
Upmc Presbyterian Montefiore Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
UPMC Presbyterian Shadyside, Pittsburgh, Pennsylvania, United States

Preventing the Spread of Infection in Nursing Homes

Not Applicable

Completed

Conditions: Staphylococcus Aureus

Interventions: Other: Targeted gown and glove use

First Posted Date: 2017-10-24

Last Posted Date: 2024-03-21

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 367

Registration Number: NCT03319368

Locations: 🇺🇸
Lorien Riverside, Belcamp, Maryland, United States
🇺🇸
Lorien Mays Chapel, Lutherville-Timonium, Maryland, United States

Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection

Phase 2

Completed

Conditions: Hepatitis B

Interventions: Drug: Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
Drug: Ledipasvir 90 MG
Drug: Sofosbuvir 400 MG [Sovaldi]

First Posted Date: 2017-10-17

Last Posted Date: 2021-09-20

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 21

Registration Number: NCT03312023

Locations: 🇺🇸
Institute of Human Virology (IHV), University of Maryland Baltimore, Baltimore, Maryland, United States

HIV-1 and Brain Interaction on Smoking Comorbidity

Not Applicable

Withdrawn

Conditions: Smoking

Interventions: Other: Tobacco smoking and nicotine patch

First Posted Date: 2017-10-12

Last Posted Date: 2020-03-10

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03308331

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy